Consistent with the hypothesis of TGFβ blockade in APL, our results did not show significant differences in cell growth inhibition and apoptosis when NB4 and NB4 cells treated with TGFβ were compared, suggesting that APL cells are resistant to the anti-proliferative effects of this cytokine. The gene discussed is TGFB1; the disease is acute promyelocytic leukemia.